Maharashtra Woman Dies Of Rabies 3 Days After Completing Vaccine Course

Kolhapur: A 21-year-old woman from Maharashtra’s Kolhapur died of rabies three days after she completed the anti-rabies vaccination course.

The woman, Srishti Shinde, was bitten by a stray dog on February 3 on Bhausingji Road. She was on her way to Shaniwar Peth and had stopped on the road to answer a phone call when a stray dog bit her on her leg.

However, days later, she developed a fever and lost strength in both her legs.

Srishti Shinde was admitted to a private hospital where several tests were conducted and was put on a ventilator after her condition worsened. The test reports revealed that she was infected with rabies.

Shinde was later taken to a government hospital for further treatment, but she died the next day.

Srishti Shinde’s death has raised questions about how she contracted rabies despite completing the vaccine course. Her family is asking whether the vaccine was not kept at the required temperature.

Related Posts

India eyes Russia, Brazil, Netherlands for pharma export growth

New Delhi: India plans to increase pharmaceutical exports to Russia, the Netherlands and Brazil, according to two industry sources aware of the matter, aiming to expand its presence beyond the…

NPPA fixes retail price of 42 new drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 42 new drugs as per the provisions of the Drugs Prices Control Order (DPCO), 2013, including…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India eyes Russia, Brazil, Netherlands for pharma export growth

India eyes Russia, Brazil, Netherlands for pharma export growth

Vibrant Gujarat regional conference to showcase North Gujarat’s pharma sector strength: Gujarat govt

Vibrant Gujarat regional conference to showcase North Gujarat’s pharma sector strength: Gujarat govt

Zydus launches VaxiFluTM India’s first trivalent influenza vaccine

Zydus launches VaxiFluTM India’s first trivalent influenza vaccine

NPPA fixes retail price of 42 new drugs

NPPA fixes retail price of 42 new drugs